Blockchain Registration Transaction Record
GeoVax Announces Q2 2025 Financial Results and Corporate Update
GeoVax Labs to discuss Q2 2025 financial results and corporate updates, highlighting advancements in vaccines for COVID-19 and cancer therapies. Join the live webcast.

GeoVax's upcoming financial results and corporate update are significant for investors and the healthcare sector, as the company is pioneering vaccines and therapies for critical health challenges, including COVID-19 and cancer. Their progress in clinical trials could lead to breakthroughs in treatment options for immunocompromised patients and those with solid tumors, marking a potential turning point in how these conditions are managed.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x82f2efc2b22cb4a7108a1b24b619264b1010fac07a1fa3e6454c1fa71edf3bf4 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | kiwiCARN-8ec6865be0e320696edeb4f9f33ce3a6 |